The Neutrophil‐to‐Lymphocyte Ratio Is an Independent Inflammatory Biomarker for Adverse Events in Patients With Atrial Fibrillation: Insights From the Murcia AF Project II (MAFP‐II) Cohort Study

Documenti analoghi

• Evaluation of the Presence of Native Valvular Disease in Patients With Atrial Fibrillation Using the EHRA (Evaluated Heartvalves, Rheumatic, or Artificial) Classification
  di: Antonio Escolar Conesa, et al.
  Pubblicazione: (2025)
• Incidence Rate and Predictors of Intracranial Hemorrhage in Patients With Atrial Fibrillation: A Report From the Nationwide COOL‐AF Registry
  di: Rungroj Krittayaphong, et al.
  Pubblicazione: (2024)
• Effect of Neutrophil-to-Lymphocyte Ratio on Post-TAVR Mortality and Periprocedural Pulmonary Hypertension
  di: Xin Gao, et al.
  Pubblicazione: (2024)
• C‐Reactive Protein–Albumin–Lymphocyte (CALLY) Index as an Independent Risk Factor for Postoperative Atrial Fibrillation Recurrence
  di: Ye Deng, et al.
  Pubblicazione: (2025)
• Incremental Value of NT‐proBNP Over HCM‐AF Score in Risk Stratification for Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy
  di: Yi‐Peng Gao, et al.
  Pubblicazione: (2026)